These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26455246)

  • 1. Osteoprotegerin is associated with depletion of circulating endothelial progenitor cells and elevation in pulmonary arterial pressure in patients with systolic heart failure.
    Zhang H; Feng L; Wan Q; Hong Y; Li Y; Cheng G; Han X
    Acta Cardiol; 2015 Aug; 70(4):435-41. PubMed ID: 26455246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep-disordered breathing is associated with depletion of circulating endothelial progenitor cells and elevation in pulmonary arterial pressure in patients with decompensated systolic heart failure.
    Zhang H; Feng L; Wan QL; Hong Y; Li YM; Cheng GC; Han XQ
    J Geriatr Cardiol; 2015 Jul; 12(4):424-30. PubMed ID: 26346897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure.
    Berezin AE; Kremzer AA
    Diabetes Metab Syndr; 2014; 8(3):138-44. PubMed ID: 25082501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure.
    Loncar G; Bozic B; Dimkovic S; Prodanovic N; Radojicic Z; Cvorovic V; Putnikovic B; Popovic V
    J Endocrinol Invest; 2011 Mar; 34(3):e78-85. PubMed ID: 20820131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure.
    Michowitz Y; Goldstein E; Wexler D; Sheps D; Keren G; George J
    Heart; 2007 Sep; 93(9):1046-50. PubMed ID: 17277352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preserved autonomic functions may provide the asymptomatic clinical status in heart failure despite advanced left ventricular systolic dysfunction.
    Kocaman SA; Taçoy G; Ozdemir M; Açıkgöz SK; Cengel A
    Anadolu Kardiyol Derg; 2010 Dec; 10(6):519-25. PubMed ID: 20952357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between RANKL and neuroendocrine activation in elderly males with heart failure.
    Loncar G; Bozic B; Cvorovic V; Radojicic Z; Dimkovic S; Markovic N; Prodanovic N; Lepic T; Putnikovic B; Popovic-Brkic V
    Endocrine; 2010 Feb; 37(1):148-56. PubMed ID: 20963564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension.
    Jasiewicz M; Knapp M; Waszkiewicz E; Musiał WJ; Kamiński KA
    Pol Arch Med Wewn; 2014; 124(11):579-86. PubMed ID: 25188298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial progenitor cells as markers for severity of ischemic chronic heart failure.
    Berezin AE; Kremzer AA
    J Card Fail; 2014 Jun; 20(6):438-47. PubMed ID: 24594088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.
    Diller GP; van Eijl S; Okonko DO; Howard LS; Ali O; Thum T; Wort SJ; Bédard E; Gibbs JS; Bauersachs J; Hobbs AJ; Wilkins MR; Gatzoulis MA; Wharton J
    Circulation; 2008 Jun; 117(23):3020-30. PubMed ID: 18519847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure.
    Zuber M; Cuculi F; Attenhofer Jost CH; Kipfer P; Buser P; Seifert B; Erne P
    Scand Cardiovasc J; 2009; 43(5):324-9. PubMed ID: 19247872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
    J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
    Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
    Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension.
    Mauritz GJ; Rizopoulos D; Groepenhoff H; Tiede H; Felix J; Eilers P; Bosboom J; Postmus PE; Westerhof N; Vonk-Noordegraaf A
    Am J Cardiol; 2011 Dec; 108(11):1645-50. PubMed ID: 21890089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
    Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure.
    Pfister R; Müller-Ehmsen J; Hagemeister J; Hellmich M; Erdmann E; Schneider CA
    Intern Med J; 2011 Jun; 41(6):467-72. PubMed ID: 20214692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease.
    Yue WS; Wang M; Yan GH; Yiu KH; Yin L; Lee SW; Siu CW; Tse HF
    Am J Cardiol; 2010 Nov; 106(9):1248-54. PubMed ID: 21029820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.